Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis‐associated intrahepatic cholangiocarcinoma
Authors:
- 6 December 2013
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 109 (5) , 494-499
Abstract
Background Hepatolithiasis-associated intrahepatic cholangiocarcinoma (IHHCC) has a poor prognosis, because of lower curative resection rate when diagnosed in the advanced stage. There has been insufficient data regarding prognostic factors and the impact of palliative resection on its outcome. Methods A retrospective analysis of 78 eligible patients with stage IV IHHCC was performed. The potential prognostic factors were assessed by univariate and multivariate analyses. Patients were divided into groups A (margin positive) and B (nonresection) based on surgical methods. Demographic and operative data were compared. Results Of 78 surgeries, R1 was achieved in 11, R2 in 21 and nonresection in 46 patients. Median overall survival (OS) of the entire cohort was 10.5 months. Surgery (P < 0.01), tumor differentiation (P = 0.03), AJCC stage (P < 0.01), and serum CEA levels (P < 0.01) were independent prognostic factors. Significant differences were achieved in OS (P < 0.01), operation time (P < 0.01), estimated blood loss (P < 0.01), and postoperative complications (P = 0.02) between groups A and B. Conclusions For patients with stage IV IHHCC, palliative resection is a rational and effective treatment. Normal serum CEA levels, higher tumor differentiation, and stage IVa predict good prognosis in stage IV IHHCC. J. Surg. Oncol. 2014 109:494–499.Keywords
Funding Information
- Medical Scientific Research Foundation of Guangdong Province, China (WSTJJ20091101410811197708049311)
- Science and Technology Planning Project of Guangdong Province, China (00707050128460019)
This publication has 30 references indexed in Scilit:
- A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in EuropeAnnals of Oncology, 2013
- Surgical outcomes of intrahepatic cholangiocarcinomaSurgery Today, 2011
- Epidemiological trends in incidence and mortality of hepatobiliary cancers in GermanyScandinavian Journal of Gastroenterology, 2011
- Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B VirusAnnals of Surgical Oncology, 2011
- Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated CholangiocarcinomaAsian Journal of Surgery, 2009
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2008
- Clinical impact of the surgical margin status in hepatectomy for solitary mass‐forming type intrahepatic cholangiocarcinoma without lymph node metastasesJournal of Surgical Oncology, 2007
- Treatment of Non-Endemic Hepatolithiasis in a Western Country. The Role of Hepatic ResectionThe Annals of The Royal College of Surgeons of England, 2006
- Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanismsJournal of Hepato-Biliary-Pancreatic Surgery, 2005